CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-15 | Valamehr Bahram Chief Development Officer | Sale | −8,404 | $92.64 | $779K | 99,963 |
| 2021-03-15 | Valamehr Bahram Chief Development Officer | Sale | −3,205 | $93.75 | $300K | 96,758 |
| 2021-03-15 | Valamehr Bahram Chief Development Officer | Sale | −1,018 | $94.59 | $96K | 95,740 |
| 2021-03-15 | Valamehr Bahram Chief Development Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 16,156 | ||
| 2021-03-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −3,298 | $78.60 | $259K | 94,722 |
| 2021-03-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −4,627 | $79.58 | $368K | 90,095 |
| 2021-03-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −5,174 | $80.73 | $418K | 84,921 |
| 2021-03-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −2,993 | $81.60 | $244K | 81,928 |
| 2021-03-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −2,480 | $83.46 | $207K | 79,448 |
| 2021-03-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −2,728 | $84.20 | $230K | 76,720 |
| 2021-03-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −2,900 | $85.50 | $248K | 73,820 |
| 2021-03-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −800 | $86.70 | $69K | 73,020 |
| 2021-02-18 | Wolchko J Scott President and CEO | Option exercise | +20,000 | $6.62 | $132K | 413,793 |
| 2021-02-18 | Wolchko J Scott President and CEO | Sale | −1,401 | $99.08 | $139K | 412,392 |
| 2021-02-18 | Wolchko J Scott President and CEO | Sale | −1,848 | $100.48 | $186K | 410,544 |
| 2021-02-18 | Wolchko J Scott President and CEO | Sale | −2,602 | $101.42 | $264K | 407,942 |
| 2021-02-18 | Wolchko J Scott President and CEO | Sale | −8,602 | $102.26 | $880K | 399,340 |
| 2021-02-18 | Wolchko J Scott President and CEO | Sale | −5,547 | $103.16 | $572K | 393,793 |
| 2021-02-18 | Wolchko J Scott President and CEO | Option exercise · Stock Option (right to buy) | −20,000 | 14,846 | ||
| 2021-01-22 | Wolchko J Scott President and CEO | Option exercise | +10,000 | $2.73 | $27K | 403,793 |
Page 22 of 26 · 503 trades